# US 2023/0390210 A1 · Modified release softgel capsules

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0390210 A1
- Document ID: US20230390210A1
- Status: Published application
- Kind: A1
- Application number: 18/031,669
- Filed: 2021-10-15
- Published: 2023-12-07
- Earliest claimed: 2020-10-16
- Assignees: R.P. Scherer Technologies, LLC
- Applicants: R.P. Scherer Technologies, LLC
- Inventors: Karunakar Sukuru; Qi Fang
- Web page: https://patentgrep.com/patent/US20230390210A1

## CPC

- A61K 9/4866: {Organic macromolecular compounds}
- A61K 9/4816: {Wall or shell material}
- A61K 9/4825: {Proteins, e.g. gelatin (gelatin capsule shells with substantial amounts of other macromolecular substances A61K9/4816)}
- A61K 31/135: having aromatic rings {, e.g. ketamine, nortriptyline (methadone A61K31/137)}
- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A61K 31/202: having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557)
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Described are modified release softgel capsules including a pH dependent shell composition that encapsulated a controlled release fill composition, methods of preparation thereof, and methods of use thereof. The pH dependent shell composition may be characterized in that the delayed release nature of the capsules may be achieved without a separate pH dependent coating or added conventional pH dependent polymers. The softgels provide a dual controlled release platform which facilitates delivery of the active agent to a target location in the gastrointestinal tract and a controlled release profile of the active agent at said target location in the gastrointestinal tract.

## Claims

### Claim 1

A modified release softgel capsule comprising:
(a) a controlled release fill composition comprising:
(i) at least one active agent; and
(ii) a controlled release material; and
(b) a pH dependent shell composition encapsulating the fill composition, wherein the pH dependent shell composition comprises gelatin, pectin, and dextrose.

### Claim 2 (depends on 1)

The modified release softgel capsule of claim 1, wherein the controlled release material comprises polyethylene oxide, cellulose derivative, a gum, or a combination thereof.

### Claim 3 (depends on 2)

The modified release softgel capsule of claim 2, wherein the controlled release material comprises polyethylene oxide having a number average molecular weight of from about 0.05M Dalton to about 15M Dalton.

### Claim 4 (depends on 2)

The modified release softgel capsule of claim 2, wherein the controlled release material comprises a cellulose derivative selected from the group consisting of microcrystalline cellulose, sodium carboxymethyl cellulose, methylcellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, and a combination thereof.

### Claim 5 (depends on 2)

The modified release softgel capsule of claim 2, wherein the controlled release material comprises a gum selected from the group consisting of gum tragacanth, gum acacia, guar gum, xanthan gum, locust bean gum, and a combination thereof.

### Claim 6 (depends on 1)

The modified release softgel capsule of claim 1, wherein the controlled release material is present in the controlled release fill composition in an amount of at least about 8 wt. % and up to about 65 wt. %, based on a total weight of the controlled release fill composition.

### Claim 7 (depends on 1)

The modified release softgel capsule of claim 1, wherein the controlled release fill composition further comprises (iii) a hydrophilic carrier having a number average molecular weight of from about 200 Daltons to about 5000 Daltons.

### Claim 8 (depends on 7)

The modified release softgel capsule of claim 7, wherein the hydrophilic carrier comprises polyethylene glycol, propylene glycol, water, or a combination thereof.

### Claim 9 (depends on 7)

The modified release softgel capsule of claim 7, wherein the hydrophilic carrier is present in the controlled release fill composition in an amount of above 0 wt. % and up to about 70 wt. %, based on a total weight of the controlled release fill composition.

### Claim 10 (depends on 1)

The modified release softgel capsule of claim 1, wherein the at least one active agent is present in the controlled release fill composition in an amount of about 5 wt. % to about 60 wt. %, based on the total weight of the controlled release fill composition.

### Claim 11 (depends on 1)

The modified release softgel capsule of claim 1, wherein less than about 85% is released after 0.5 hours based on a fiber optic dissolution test using Apparatus II using a paddle speed of 50 rpm in pH 6.8 phosphate buffer, optionally with Pancreatin, at 37° C.

### Claim 12 (depends on 1)

The modified release softgel capsule of claim 1, wherein the modified release softgel capsule is annealed.

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The modified release softgel capsule of claim 1, wherein the pH dependent shell composition further comprises a plasticizer.

### Claim 16

(canceled)

### Claim 17

(canceled)

### Claim 18 (depends on 1)

The modified release softgel capsule of claim 1, wherein the pH dependent shell composition comprises about 25 wt. % to about 80 wt. % of a gelatin, based on the dry pH dependent shell composition weight.

### Claim 19 (depends on 1)

The modified release softgel capsule of claim 1, wherein the pH dependent shell composition comprises about 2 wt. % to about 20 wt. % of pectin, based on the dry pH dependent shell composition weight.

### Claim 20 (depends on 1)

The modified release softgel capsule of claim 1, wherein the pH dependent shell composition comprises about 0.005 wt. % to about 4 wt. % of dextrose, based on the dry pH dependent shell composition weight.

### Claim at position 21

-28. (canceled)

### Claim 29 (depends on 1)

The modified release softgel capsule of claim 1 that is free of additional pH dependent polymers.

### Claim 30 (depends on 1)

The modified release softgel capsule of claim 1, wherein the pH dependent shell composition has a viscosity ranging from about 110,000 cPs to about 125,000 cPs.

### Claim 31 (depends on 1)

The modified release softgel capsule of claim 1, wherein the pH dependent shell composition has a gelatin to pectin w:w ratio ranging from about 2:1 to about 20:1.

### Claim 32

(canceled)

### Claim 33 (depends on 1)

The modified release softgel capsule of claim 1, wherein the controlled release fill composition has a w:w ratio of the controlled release material to the at least one active agent ranging from about 10:1 to about 1:10.

### Claim 34 (depends on 1)

The modified release softgel capsule of claim 1, wherein the at least one active agent is selected from pharmaceutically active ingredients, nutraceuticals, and a combination thereof.

### Claim at position 28

-37. (canceled)

### Claim 38 (depends on 1)

A process of preparing a modified release softgel capsule according to claim 1 comprising:
(a) preparing the controlled release fill composition; and
(b) encapsulating the controlled release fill composition with the pH dependent shell composition.

### Claim 39 (depends on 38)

The process of claim 38, further comprising drying the encapsulated modified release softgel capsule.

### Claim 40 (depends on 38)

The process of claim 38, further comprising annealing the modified release softgel capsule.

### Claim at position 32

-46. (canceled)

### Claim 47

A method for tuning the dissolution location and profile of a modified release softgel capsule comprised of a controlled release fill composition encapsulated in a pH dependent shell composition, the method comprising:
adjusting at least one of i)-iv) to control dissolution location of the pH dependent shell composition along the gastrointestinal tract of a subject:
i) amounts of at least one of pectin, gelatin, dextrose, and plasticizer in the pH dependent shell composition;
ii) annealing temperature of the modified release softgel capsule;
iii) annealing duration of the modified release softgel capsule; or
iv) ribbon thickness of the pH dependent shell composition; and
adjusting at least one of (v)-(vii) to attain a target dissolution profile of the at least one active agent:
v) amount of a controlled release material in the controlled release fill composition, or
vi) annealing temperature of the modified release softgel capsule; or
vii) annealing duration of the modified release softgel capsule.

### Claim 48 (depends on 1)

A method of treating a condition comprising, administering to a subject in need thereof the modified release softgel capsule according to claim 1.

### Claim 49

A modified release softgel capsule comprising:
(a) a controlled release fill composition comprising:
(i) at least one active agent; and
(ii) a polyethylene oxide having a number average molecular weight of from about 0.05M Dalton to about 15M Dalton; and
(iii) optionally a hydrophilic carrier; and
(b) a pH dependent shell composition encapsulating the controlled release fill composition, wherein the pH dependent shell composition comprises gelatin, pectin, dextrose, and optionally a plasticizer.

### Claim 50 (depends on 49)

A method of preparing a modified release softgel capsule according to claim 49 comprising:
mixing at least one active agent with polyethylene oxide and optionally a hydrophilic carrier to form a controlled release fill composition;
encapsulating the controlled release fill composition in a pH dependent shell composition comprising gelatin, pectin, dextrose, and optionally a plasticizer; and
annealing the encapsulated controlled release fill composition.

### Claim at position 37

-53. (canceled)

### Claim 54

A modified release softgel capsule comprising:
(a) a controlled release fill composition comprising:
(i) at least one active agent; and
(ii) a controlled release material; and
(b) a pH dependent shell composition encapsulating the controlled release fill composition.

### Claim at position 39

-71. (canceled)
